Radio and PodcastLive Radio & Podcasts

Search Radio and Podcast

Podcasts›OncLive® On Air›S19 Ep3: FDA Approval Insights: Ropeginterferon Alfa-2b Ushers in Long-Awaited New Treatment Option for Essential Thrombocythemia

Science & Medicine

S19 Ep3: FDA Approval Insights: Ropeginterferon Alfa-2b Ushers in Long-Awaited New Treatment Option for Essential Thrombocythemia

OncLive® On Air by Audioboom

Oct 2, 202613:20Science & Medicine

In today’s episode, we welcomed Ruben Mesa, MD, FACP, who outlined the significance of the August 2026 FDA approval of ropeginterferon alfa-2b-njft (Besremi) for the treatment of adult patients with essential thrombocyth...

Related Episodes

Continue listening to more episodes from OncLive® On Air.

S19 Ep2: FDA Approval Insights: Daraxonrasib for Metastatic Pancreatic Ductal Adenocarcinoma

Sep 30, 2026 - 12:05

In today’s episode, we spoke with Kim A. Reiss Binder, MD, about the August 2026 FDA approval of daraxonr...

S19 Ep2: Resistance Patterns Shape FGFR Inhibitor Sequencing in Cholangiocarcinoma

Sep 30, 2026 - 16:04

In this episode, we spoke with Arndt Vogel, MD, a faculty member at the University of Toronto Institute o...

S19 Ep1: Subcutaneous Therapies Bolster Administration Options in Multiple Myeloma

Sep 30, 2026 - 14:07

In this episode, produced in coordination with Oncology Nursing News ®, Beth Faiman, PhD, MSN, APN-BC, AO...

S18 Ep50: Navigating DLL3-Targeting T-Cell Engagers and the Evolving Small Cell Lung Cancer Treatment Landscape

Sep 30, 2026 - 17:33

In today's episode, we spoke with Alissa Cooper, MD, and Noura Choudhury, MD. Dr Cooper is a physician at...

S18 Ep49: Start Earlier and Find Your Community: Navigating the Fellowship-to-Faculty Transition Through Mentorship and Specialty-Focused Meetings

Sep 30, 2026 - 24:45

In today's episode, we spoke with Jacqueline Aredo, MD, and Benjamin Bleiberg, MD. Dr Aredo is a thoracic...